Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Plasmodium falciparum NMT substrates are involved in a variety of

Frontiers Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy

N-myristoylation reaction and organisation of GNAT and NMT a Cartoon

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Design and synthesis of inhibitors of Plasmodium falciparum N- myristoyltransferase, a promising target for antimalarial drug discovery. - Abstract - Europe PMC

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. - Abstract - Europe PMC

Recombinant NMT myristoylates a Leishmania substrate protein in E.

Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase

Molecules, Free Full-Text

How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development